Monsalve FA, Rojas A, Gonzalez I, Perez R, Añasco C, Romero J, Araya P, Santos LS, Delgado-Lopez F. RID: Evaluation of the Possible Inhibiting Effect of the Proinflammatory Signaling Induced by TNF-
α through NF-
κβ and AP-1 in Two Cell Lines of Breast Cancer.
Mediators Inflamm 2020;
2020:2707635. [PMID:
32655311 PMCID:
PMC7327562 DOI:
10.1155/2020/2707635]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2020] [Revised: 04/16/2020] [Accepted: 05/11/2020] [Indexed: 02/07/2023] Open
Abstract
Receptor internalization and degradation (RID), is a transmembrane protein coded within the E3 region expression cassette of adenoviruses. RID downregulates the cell surface expression of epidermal growth factor receptor (EGFR), tumor necrosis factor receptor (TNFR), and apoptosis antigen 1 (FAS), causing a reduction of the effects of their respective ligands. In addition, RID inhibits apoptosis by decreasing the secretion of TNF-related apoptosis-inducing ligand (TRAIL) by normal tissue cells. In this article, we report that RID inhibited chemokine expression in human breast cancer cell line MDA-MB-231 but showed no effect in cell line MCF7. These dissimilar results may be due to the different molecular and functional properties of both cell lines. Therefore, it is necessary to replicate this study in other breast cancer cell models.
Collapse